Colossal Biosciences Inc., a biotechnology startup working to resurrect extinct animals, has raised $120 million from investors including filmmaker
The latest cash influx is an extension of a $200 million funding round the startup
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
